PATENT CLAIM ANALYSIS

Application Number: 15750716
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
The invention provides human antibodies against rabies and methods of using the same.

Claim (Index 1):
An antibody that specifically binds to rabies virus G protein, wherein the antibody comprises a heavy chain variable (VH) domain comprising the following complementarity determining regions (CDRs):\n (a) a CDR-H1 comprising the amino acid sequence of GFTFSYFAMH (SEQ ID NO: 1); (b) a CDR-H2 comprising the amino acid sequence of TIGTGGGTYYADSVKG (SEQ ID NO: 2); and (c) a CDR-H3 comprising the amino acid sequence of CARDNALRSFDWLFYSFDY (SEQ ID NO: 3).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11890317', '12767182', '14402644', '11590126', '11978742']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7419140070906168
- 35 USC 102 Novelty (BERT): 0.5665514646245083
- Combined Prediction Score: 0.724377752844006
- Mean Citation Score: 393.69787600000006
- Max Citation Score: 448.26633
- Similarity Product: 370.3173002874005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test